Comparison of azithromycin and co-amoxiclav in the treatment of acute tracheobronchitis and acute infectious exacerbations of chronic bronchitis in adults

Journal of International Medical Research

Volumn 24, Issue 5, 1996, Pages 407-418

  Biebuyck, X A ^a  

^a NONE   (Belgium)

Author keywords

Azithromycin; Bronchitis; Co amoxiclav; Community acquired infection; Compliance; Tolerance

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN;

ADULT; AGED; ARTICLE; AUTONOMIC NEUROPATHY; BRONCHITIS; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC BRONCHITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; GYNECOLOGIC DISEASE; HUMAN; LARYNGOTRACHEOBRONCHITIS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTICENTER STUDY; MUSCULOSKELETAL DISEASE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; RESPIRATORY TRACT DISEASE; SKIN MANIFESTATION; URINARY TRACT DISEASE;

EID: 0029828297     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/030006059602400502     Document Type: Article

References (13)

1. Moroni M, Franzetti F, Antinori S: Antibiotic therapy in bronchopulmonary infections. Ann Ital Med Int 1992; 7 (Suppl 3): 86S-93S.
2. Davies BI, Measen FPV: Treatment of Branhamella catarrhalis infections. J Antimicrob Chemother 1990; 25: 1-7.
3. Thom DH, Grayston JI, Wang SP, et al: Chlamydia pneumoniae strain TWAR, Mycoplasma pneumoniae, and viral infections in acute respiratory disease in a university student health clinic population. Am J Epidemiol 1990; 132: 248-256.
4. Morandini G, Perduca M, Zannini G, et al: Clinical efficacy of azithromycin in lower respiratory tract infections. J Chemother 1993; 5: 32-36.
5. Principi N, Marchisio P, Biasini G, et al: Azithromycin versus erythromycin in the treatment of paediatric community-acquired pneumonia. Eur J Clin Res 1993; 4: 127-133.
6. Meinert CL: Sample size and power estimates. In: Clinical trials: design, conduct and analysis. Monographs in epidemiology and biostatistics, 1986; 8: 71-89. Oxford University Press.
7. Sternon J and collaborative group: Open randomized study comparing doxycycline and co-amoxiclav in the treatment of acute suppurative tracheobronchitis in adults. J Int Med Res 1995; 23: 369-376.
8. Hoepelman AIM, Sips AP, van Helmond JLM, et al: A single-blind comparison of 3-day azithromycin and 10-day co-amoxiclav treatment of acute lower respiratory tract infections. J Antimicrob Chemother 1993; 31 (Supple E): 147-152.
9. Bradbury F: Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection. J Antimicrob Chemother 1993; 31 (Suppl. E): 153-162.
10. Dunn CJ, Barradell LB: Azithromycin - a review of its pharmacological properties and use as a 3-day therapy in respiratory tract infections. Drugs 1996; 51: 483-505.
11. Sternon J, Leclerq P, Knepper C, et al: Azithromycin compared with clarithromycin in the treatment of adult patients with acute purulent tracheobronchitis: a cost-of-illness study. J Int Med Res 1995; 23: 413-422.
12. Baldwin DR, Wise R, Andrews JM, et al: Azithromycin concentrations at the sites of pulmonary infection. Eur Resp J 1990; 3: 886-890.
13. Wise R: The pharmacokinetics of azithromycin. Rev Contemp Pharmacother 1994; 5: 329-340.